Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Naigen Bioscience Inc NAGE

Healthcare Biotechnology
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD... see more

Current News (NDAQ:NAGE)

Niagen Bioscience Launches Tru Niagen® Beauty - The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside)

Business Wire November 13, 2025

Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID

Business Wire November 12, 2025

Niagen Bioscience Announces $10 Million Share Repurchase Program

Business Wire November 6, 2025

Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook

Business Wire November 4, 2025

Niagen Bioscience to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

Business Wire October 21, 2025

Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth

Business Wire October 6, 2025

Niagen Bioscience's Pharmaceutical-Grade Niagen(TM) IV and Injections Now Available at over 50 iCRYO Clinics and More than 900 Total Clinics Nationwide

Business Wire October 1, 2025

AboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+

Business Wire September 16, 2025

Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook

Business Wire August 6, 2025
View More News ››

Opinion & Analysis (NDAQ:NAGE)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NAGE)

Nice coverage and valuation article on Chromadex

ChromaDex: Blazing Ahead Of Ponce De Leon (NASDAQ:CDXC) | Seeking Alpha seekingalpha.com/article/4378493-chromadex-blazing-ahead-of...
jthottam - December 20, 2020

Keeping people as young and healthy as possible

sounds like a pretty good thing. Bought first shares today
scopro - May 3, 2019

This one has me fustrated.

I love the product. I use the product. But the stock is killing me. When it ran to 6 bucks. I thought, here we go. On our way to 20...
HERO547 - January 15, 2017

This report will be the game changer.

ChromaDex to Report First Quarter 2016 Financial Results on Thursday, May 12, 2016 Company Will Host Investor Conference Call on...
HERO547 - May 10, 2016

We be ringing the bell.

https://finance.yahoo.com/news/chromadex-corp-nasdaq-cdxc-ring-140000216.html
HERO547 - May 5, 2016

Getting closer to main stream news sources.

http://www.newsweek.com/vitamin-stops-aging-process-organs-study-453526
HERO547 - May 2, 2016
View more Bullboard ››

TomaGold Corp.

TomaGold Corp.

TomaGold Corporation, together with its subsidiaries, engages in the acquisition, exploration, assessment, and development of ...
View More »